Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn’s disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) trial

OBJECTIVE: To evaluate open-label adalimumab therapy for clinical effectiveness, fistula healing, patient-reported outcomes and safety in Canadian patients with moderate to severe Crohn’s disease (CD) who were either naive to or previously exposed to antitumour necrosis factor (anti-TNF) therapy. ME...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Panaccione, Remo, Loftus, Edward V, Binion, David, McHugh, Kevin, Alam, Shamsul, Chen, Naijun, Guérette, Benoît, Mulani, Parvez, Chao, Jingdong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Pulsus Group Inc 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186726/
https://ncbi.nlm.nih.gov/pubmed/21912766
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia